Clinical Trial
doi: 10.1016/s0140-6736(85)92559-0.
Oral immunisation with killed Haemophilus influenzae for protection against acute bronchitis in chronic obstructive lung disease
- PMID: 2867396
- DOI: 10.1016/s0140-6736(85)92559-0
Item in Clipboard
Clinical Trial
Oral immunisation with killed Haemophilus influenzae for protection against acute bronchitis in chronic obstructive lung disease
Lancet.
1985 Dec.
Abstract
Fifty patients with chronic obstructive lung disease were randomly allocated to three groups, to assess whether an oral vaccine containing non-typable Haemophilus influenzae protected against acute bronchitis. The double-blind prospective study over a three-month winter period included two placebo groups and one test group. Oral immunisation with H influenzae induced a tenfold reduction in the incidence of infection (p less than 0.001). During the subsequent winter, without further immunisation, protection by the vaccine was no longer statistically significant. There was no clear correlation between clinical protection and either carriage of H influenzae or the level of antibody to H influenzae antigen in saliva.
Similar articles
-
Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2014 Sep 9;(9):CD010010. doi: 10.1002/14651858.CD010010.pub2. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2017 Jun 19;6:CD010010. doi: 10.1002/14651858.CD010010.pub3 PMID: 25201571 Updated. Review.
-
A controlled trial of a killed Haemophilus influenzae vaccine for prevention of acute exacerbations of chronic bronchitis.Aust N Z J Med. 1991 Aug;21(4):427-32. doi: 10.1111/j.1445-5994.1991.tb01346.x. Aust N Z J Med. 1991. PMID: 1953532 Clinical Trial.
-
Protection against recurrent acute bronchitis after oral immunization with killed Haemophilus influenzae.Med J Aust. 1990 Apr 16;152(8):413-6. doi: 10.5694/j.1326-5377.1990.tb125268.x. Med J Aust. 1990. PMID: 2184330 Clinical Trial.
-
Efficacy of oral immunization against non-typable Haemophilus influenzae in man.Int J Immunopharmacol. 1987;9(3):283-8. doi: 10.1016/0192-0561(87)90052-x. Int J Immunopharmacol. 1987. PMID: 3301699 Clinical Trial.
-
Haemophilus influenzae oral whole cell vaccination for preventing acute exacerbations of chronic bronchitis.Cochrane Database Syst Rev. 2003;(3):CD001958. doi: 10.1002/14651858.CD001958. Cochrane Database Syst Rev. 2003. Update in: Cochrane Database Syst Rev. 2006 Oct 18;(4):CD001958. doi: 10.1002/14651858.CD001958.pub2 PMID: 12917917 Updated. Review.
Cited by
-
The Lung Immune Response to Nontypeable Haemophilus influenzae (Lung Immunity to NTHi).J Immunol Res. 2015;2015:706376. doi: 10.1155/2015/706376. Epub 2015 May 31. J Immunol Res. 2015. PMID: 26114124 Free PMC article. Review.
-
Mucosal vaccines for the prevention of influenza.Drugs. 1995 Oct;50(4):587-94. doi: 10.2165/00003495-199550040-00001. Drugs. 1995. PMID: 8536547 Review. No abstract available.
-
Is there a role for a mucosal influenza vaccine in the elderly?Drugs Aging. 1999 Sep;15(3):169-81. doi: 10.2165/00002512-199915030-00001. Drugs Aging. 1999. PMID: 10503810 Review.
-
Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review.Clin Microbiol Rev. 2001 Apr;14(2):336-63. doi: 10.1128/CMR.14.2.336-363.2001. Clin Microbiol Rev. 2001. PMID: 11292642 Free PMC article. Review.
-
Nontypeable Haemophilus influenzae: pathogenesis and prevention.Microbiol Mol Biol Rev. 1998 Jun;62(2):294-308. doi: 10.1128/MMBR.62.2.294-308.1998. Microbiol Mol Biol Rev. 1998. PMID: 9618443 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
